This invention is directed to the crystalline potassium salt of a lipoxin A4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.
申请公布号
CA2670791(C)
申请公布日期
2017.01.03
申请号
CA20072670791
申请日期
2007.12.04
申请人
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
发明人
HAAG, TILO;GROSSBACH, DANJA;WINTER, GABRIELE;SANDER, MICHAEL;BECKMANN, WOLFGANG;BARTEL, KLAUS;DINTER, CHRISTIAN
